Recently, the Sino-US Pu'an International Cancer Hospital project signed a contract with Qingdao West Coast New District. The project was jointly invested by the Philadelphia Cancer Hospital (FCCC), which won the Nobel Prize in Medicine twice, together with Qingdao Chengtou Group and Beijing Zhongjin Pu'an Investment Co., Ltd., with a total investment of 2.35 billion yuan to build “national cancer treatmentâ€. With the goal of “Demonstration Centerâ€, the company established the first clean laboratory of genetic antibodies and immunotherapy technology in the Asia-Pacific region, leading the new district to become a world-class cancer precision medical industry leader.
It is reported that the planned total construction area of ​​the project is 150,000 square meters, relying on the Philadelphia Cancer Hospital, the University of the Highlands Cancer Immunology Research Center, the TopGrade Swedish Radiation Oncology Research Institute, and the European and American oncologist resources to create an international, high-end, personalized The cancer treatment medical institution provides patients with efficient and high-quality medical services.
In terms of hardware construction, the project will introduce the most advanced international cancer treatment technology, equipment and services: the introduction of internationally advanced scintillation layered imaging and single photon emission tomography detection technology, with international advanced precision targeted therapy and gene therapy technology To create a world-class professional tumor hospital brand, while taking into account the high-end vitality rehabilitation and pension health field.
Surgical Drapes,New Nonwoven Drapes,Pediatric Universal Drapes,Banded Bag Surgical Drape
Zhende Medical Co.,Ltd , https://www.zdmedicalproduct.com